Neocell Science Pharmaceuticals Private Limited, a active private limited company, was established on 23 September 2019 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909TG2019PTC135631. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Jagiyassi Nirmala (Director), Nagaraju Nallagatla (Director), Jagiyassi Harish Kumar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.16-2-668/3 Malakpet, Hyderabad, Telangana, 500036.
U51909TG2019PTC135631
135631
23 September 2019
₹1.50 M
₹1.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Neocell Science Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagiyassi Nirmala | Director | 23 Sep 2019 | Current |
| Nagaraju Nallagatla | Director | 23 Sep 2019 | Current |
| Jagiyassi Harish Kumar | Director | 23 Sep 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neocell Science Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 86.38% increase. The company also saw a substantial fall in profitability, with a 24.77% decrease in profit. The company's net worth Soared by an impressive increase of 33.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Neocell Science Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neocell Science Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neocell Science Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neocell Science Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Neocell Science Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Neocell Science Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Jagiyassi Nirmala was appointed as a Director was appointed as a Director on 23 Sep 2019 & has been associated with this company since 6 years 3 months . was completed.
The activity Nagaraju Nallagatla was appointed as a Director was appointed as a Director on 23 Sep 2019 & has been associated with this company since 6 years 3 months . was completed.
Jagiyassi Harish Kumar was appointed as a Director was appointed as a Director on 23 Sep 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.
Progress on Neocell Science Pharmaceuticals Private Limited was registered on 23 Sep 2019 with Roc Hyderabad & aged 6 years 3 months as per MCA records. was documented.
The CIN of Neocell Science Pharmaceuticals Private Limited is U51909TG2019PTC135631.
Neocell Science Pharmaceuticals Private Limited is headquartered at H.No.16-2-668/3 Malakpet, Hyderabad, Telangana, 500036.
Neocell Science Pharmaceuticals Private Limited was incorporated on 23 September 2019.
The current directors of Neocell Science Pharmaceuticals Private Limited are
The primary industry of Neocell Science Pharmaceuticals Private Limited is Pharma.
Neocell Science Pharmaceuticals Private Limited is unlisted.
The authorized capital of Neocell Science Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX